Clinical Trial Update: Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial updates the safety and feasibility of combining gefitinib, docetaxel, and radiation therapy for patients with stage III non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)
• Taxotere (docetaxel)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED